Summit Therapeutics Share Discussion Threads

[joe shone] 21/11/2016 21:30

somebody is shorting this.it is not difficult with a share that is not traded a lot.but they will have to buy back quickly with a good rns.hope they get their fingers burnt,. i mean on nasdaq gl,joe.

[chrisatrdg] 21/11/2016 19:46

Interesting chatter today & following waterloo01 comment had a quick look & also can confirm my average is also £1.15 (owning 0.06 % of SC)but current share price is disappointing (dare not mention my wife's Buy at £1.93 last month based on my advice).

Conference next week & 9 months accounts in December might produce some activity also are we due some C-Diff test results but maybe nothing to prevent downward trend - same old same old.

Edit: Good Buy for someone today 25,000 shares at 1.72 value £43k.

Edit: Tuesday share price moving towards £1.50 !!!!!

[hugus maximus] 21/11/2016 18:03

Blimey O'Reilly the NASDAQ is currently just around 163p ... that's back down to my average again. It seems that NASDAQ investors are even more birdbrained and impatient than AIM users.

[waterloo01] 21/11/2016 17:51

Nothing material so not sure why Nasdaq is testing $10 again!



Summit Therapeutics plc submitted an application under Rule 406 requesting an
extension of a previous grant of confidential treatment for information it excluded from the Exhibits to a Form F-1 registration statement filed on January 30, 2015, as amended.
Based on representations by Summit Therapeutics plc that this information
qualifies as confidential commercial or financial information under the Freedom of
Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibit(s) will not be released to the public for the time period(s) specified: Exhibit 10.4 through November 21, 2019

[waterloo01] 21/11/2016 17:16

That's why they run trials. Doesn't matter if it looks good invivo or in animal models, it's in real patients that it matters. It's no 'slam dunk' as I'm sure Glyn and Kay would confirm. If it were the share price would be 10x, but been seriously derisked with the SRPT deal.

[abergele] 21/11/2016 16:56

Waterloo,,,Good lad,,,I feel safe here,although there is a slight danger,
but all the talking from Glyn and Kay,they will look pretty silly at this stage after all the briefings and seminars around the USA if they can't back up all this effort so far with the answers the world craves..

[waterloo01] 21/11/2016 16:33

HSBC are behind the rest. Almost all easy access is now 0.1%. With inflation, that's a minus rate.

Yes been here a while, and was very unhappy about the cost of dilution at the time, but in decent profit now and happy to hold most, if not all for the end game.

(Actually picked up a few at 88p but average must be £1.15ish)

[abergele] 21/11/2016 16:28

Heavens noooo waterloo...haaaa..good timing..
mind you we have all been here since conversion from pennies, and been shafted so to speak....but as we say and know,nothing has changed,just time, and the wait does seem like ages,but when you get a letter from hSBC today saying interest rates are going down from a half to a tenth of a %..what is time eh...gla

[waterloo01] 21/11/2016 16:00

I shan't mention my buying at 97p then!

[abergele] 21/11/2016 15:49

No waterloo,
only me buying 2 x lots of top ups at the wrong price yet again...does anyone get timing right I ask you...?

[waterloo01] 21/11/2016 15:22

Almost £1.00 off the high! Anything changed?

[chrisatrdg] 21/11/2016 15:17

I hope the share price does not go to 150 but todays current drop to 170 (mid price) is not good.I am hoping we may get some positives next week.

[sorrento06] 21/11/2016 15:12

With no more news until after Christmas, I can see this sleeping its way back down past 150. Come on Glyn Ffs!

[chrisatrdg] 21/11/2016 14:52

Hopefully the conference below,next Tuesday,will give us a useful update.I expect there will be a webcast at which there would be a question & answer session which may give us some insight into the recently announced recruitment announcements & hopefully more.At least we hopefully will get a feeling of the current mood in Summit.In addition the two potential positions are both to be resident in the USA which I think shows the direction Summit is going.

OPPENHEIMER & COMPANY LIFE SCIENCES SUMMIT 29 November 2016, New York City, US

Recruitment links:

[luminoso] 21/11/2016 14:34

They would probably like to but would not get Summit at this price, or any price they could afford.

[sorrento06] 21/11/2016 11:39

Why doesn't SRPT just buy Summ, sure at this price it makes more sense then a tie up.

[luminoso] 21/11/2016 11:28

Yes volatility is a major consequence of nasdaq listing, but I comfort myself with the thought of how far up the nasdaq could carry us after the good news begins to flow again from the trials.

[waterloo01] 20/11/2016 16:54

Lot's of advantages but one of the disadvantages of the Nasdaq listing, or at least once the traders arrived (and we had NO volume at all before the SRPT news)is the short term skittishness of it all. Outside of news, we now seem to be taking our share price moves as a reaction to whatever happens on Nasdaq, which seems to be inhabited by option traders and armies of small time PI's making a turn (more likely losing a fortune!).

Good to see RBC upgrading to $29 as they are one of the better independent brokers IMO but all the brokers currently have a 12 month target with an average around $26. Shame they don't do 3-5 year price targets as they would make an exiting headline!

[abergele] 18/11/2016 21:13

Can't believe my timings for top ups,£2.04,,,and £1.89...great eh...
oh well,when it.s over £2.50 again,I won't moan I suppose...gla..

[chrisatrdg] 18/11/2016 09:10

Per gmcc this morning from the other board:
'Hi Chris - thanks note both positions " Location: Cambridge, MA, USA "





"Responsible for ensuring that the assigned projects on the DMD program deliver with precise execution, quality, in time and within budgets." -"This will involve oversight of program activities for the Lead and Next Generation compounds in the DMD portfolio"

Fingers crossed they will be able to " walk the talk " good luck everyone !'

[chrisatrdg] 18/11/2016 08:05

Yesterdays tweet by Summit at least they are moving forward:

Summit Therapeutics ‏@Summitplc 18h18 hours ago

We're hiring! Details: Join our team to help fight #Duchenne and #Cdiff

[abergele] 17/11/2016 23:09

HM,
quite so,,maybe next week they will wake up and smell the coffee..gla

[hugus maximus] 17/11/2016 22:30

What a dreary week both here and on the NASDAQ, ... and for no apparent reason. I was expecting the american market to be really enthusiastic about the DMD dosing RNS but it's been a damp squib.

[abergele] 17/11/2016 19:41

thanks Chrisatrdg...doesn't inspire strangers to buy when they deceive,,the old smoke screen again..gla lth's

[chrisatrdg] 17/11/2016 16:18

For the record & in support of earlier post:

I was quoted 189.50 to Buy 1,000 shares at 12.20 today so I suggest that the previous 2 transactions of 500 & 1,000 shares were Buys not Sales.